ArticleBiomolecules2021
Antimicrobial Activity of Cyclic-Monomeric and Dimeric Derivatives of the Snail-Derived Peptide Cm-p5 against Viral and Multidrug-Resistant Bacterial Strains.
Open access · goldAbstract read
In one paragraph
Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 14 citations in OpenAlex.
- A Scoping Review of Snail Antibacterial Peptides and Proteins: From Natural Defence to Translational Prospects.Probiotics and antimicrobial proteins · 2026Article
- Phage Display-Derived Peptides Have Neutralizing Activities Against Biofilm Formation byPharmaceuticals (Basel, Switzerland) · 2026Article
- Anti-biofilm peptides can rescue fluconazole and amphotericin B efficacies against Candida albicans.Scientific reports · 2025Article
- Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options.Pharmaceuticals (Basel, Switzerland) · 2025Review
- Structural Characterization of the Dimers and Selective Synthesis of the Cyclic Analogues of the Antimicrobial Peptide Cm-p5.Antibiotics (Basel, Switzerland) · 2025Article
- Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates ofFrontiers in cellular and infection microbiology · 2024Article
- Cm-p5 Peptide Dimers Inhibit Biofilms ofInternational journal of molecular sciences · 2023Article
- Aptamers as Novel Binding Molecules on an Antimicrobial Peptide-Armored Composite Hydrogel Wound Dressing for Specific Removal and Efficient Eradication ofInternational journal of molecular sciences · 2023Article
- A Systematic Review of Second-Line Treatments in Antiviral Resistant Strains of HSV-1, HSV-2, and VZV.Cureus · 2023Review
- ABP-Finder: A Tool to Identify Antibacterial Peptides and the Gram-Staining Type of Targeted Bacteria.Antibiotics (Basel, Switzerland) · 2022Article
- Multidrug-Resistant Microbial Therapy Using Antimicrobial Peptides and the CRISPR/Cas9 System.Veterinary medicine (Auckland, N.Z.) · 2022Review
- The bacteriocin Angicin interferes with bacterial membrane integrity through interaction with the mannose phosphotransferase system.Frontiers in microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 6 institutions in 4 countries.
Melaine González-GarcíaCenter for Protein Studies, Faculty of Biology, University of Havana, 25 St, La Habana 10400, Cuba.
Fidel Morales-VicenteGeneral Chemistry Department, Faculty of Chemistry and Center for Natural Products Research, Faculty of Chemistry, University of Havana, Zapata street, La Habana 10400, Cuba.
Erbio Díaz PicoSynthetic Peptides Group, Center for Genetic Engineering and Biotechnology, P.O. Box 6162, La Habana 10600, Cuba.
Hilda GaraySynthetic Peptides Group, Center for Genetic Engineering and Biotechnology, P.O. Box 6162, La Habana 10600, Cuba.
Daniel G RiveraFaculty of Chemistry, Havana University, Zapata Street, La Habana 10400, Cuba.
Mark GrieshoberInstitute of Medical Microbiology and Hygiene, University Clinic of Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany.
Lia Raluca OlariInstitute of Molecular Virology, University Clinic of Ulm, Meyerhofstrasse. 1, 89081 Ulm, Germany.
Rüdiger GroßInstitute of Molecular Virology, University Clinic of Ulm, Meyerhofstrasse. 1, 89081 Ulm, Germany.ORCID 0000-0003-0355-7915
Carina ConzelmannInstitute of Molecular Virology, University Clinic of Ulm, Meyerhofstrasse. 1, 89081 Ulm, Germany.
Franziska KrügerInstitute of Molecular Virology, University Clinic of Ulm, Meyerhofstrasse. 1, 89081 Ulm, Germany.
Fabian ZechInstitute of Molecular Virology, University Clinic of Ulm, Meyerhofstrasse. 1, 89081 Ulm, Germany.
Caterina Prelli BozzoInstitute of Molecular Virology, University Clinic of Ulm, Meyerhofstrasse. 1, 89081 Ulm, Germany.
Janis A MüllerInstitute of Molecular Virology, University Clinic of Ulm, Meyerhofstrasse. 1, 89081 Ulm, Germany.
Alexander ZelikinDepartment of Chemistry, Aarhus University, Langelandsgade 140, 8000 Aarhus, Denmark.
Heinz RaberInstitute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany.
Dennis KubiczekInstitute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany.
Frank RosenauInstitute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany.ORCID 0000-0002-9297-6419
Jan MünchInstitute of Molecular Virology, University Clinic of Ulm, Meyerhofstrasse. 1, 89081 Ulm, Germany.ORCID 0000-0001-7316-7141
Steffen StengerInstitute of Medical Microbiology and Hygiene, University Clinic of Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany.
Barbara SpellerbergInstitute of Medical Microbiology and Hygiene, University Clinic of Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany.
Octavio L FrancoDepartment of Biotechnology, Catholic University Dom Bosco, Campo Grande and Center for Biochemical and Proteomics Analyses, Catholic University of Brasilia, Brasilia, DF 71966-700, Brazil.ORCID 0000-0001-9546-0525
Armando A Rodriguez AlfonsoCore Facility for Functional Peptidomics, Ulm Peptide Pharmaceuticals (U-PEP), Faculty of Medicine, Ulm University, 89081 Ulm, Germany.ORCID 0000-0001-5921-3770
Ludger StändkerCore Facility for Functional Peptidomics, Ulm Peptide Pharmaceuticals (U-PEP), Faculty of Medicine, Ulm University, 89081 Ulm, Germany.ORCID 0000-0002-8436-4260
Anselmo J Otero-GonzalezCenter for Protein Studies, Faculty of Biology, University of Havana, 25 St, La Habana 10400, Cuba.
Universität Ulm · DEUniversity of Havana · CUInstitute of Medical Microbiology and Hygiene · DECentro de Ingeniería Genética y Biotecnología · CUAarhus University · DKUniversidade Católica de Brasília · BR
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cm-p5 is a snail-derived antimicrobial peptide, which demonstrated antifungal activity against the pathogenic strains of
Indexed as
Amino Acid SequenceAnimalsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesAntiviral AgentsCandida albicansCell LineCell SurvivalDimerizationDrug Resistance, Multiple, BacterialGram-Negative BacteriaGram-Positive BacteriaHerpesvirus 2, HumanHumansMicrobial Sensitivity TestsSARS-CoV-2Anti-Bacterial AgentsAntimicrobial Cationic PeptidesAntiviral Agentsantibacterial activityantimicrobial peptideschemical derivativesCm-p5multiresistant microorganisms
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.